A new strategy to beat lung cancer: Chemists develop first-in-class inhibitor targeting a key epigenetic regulator

A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
Labroots

Complete Cancer Protein Inhibition Improves Anti-Tumor Immunity

The concept of immunotherapy or boosting the body’s immune system to target tumors was first practically applied in the early ...
ascopubs.org

After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor–Positive Metastatic Breast Cancer

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

New Data Underscoring Ability of Leapfrog Bio’s OncoSLX Platform to Identify Drug Retargeting Opportunities for Treating Cancer Published in Nature Portfolio Journal

Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate proprietary OncoSLX ...
Seeking Alpha

Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of ...

Results are from Acurx's ongoing scientific collaboration with Leiden University Medical Center (LUMC) partially under a grant from Health Holland to further study the mechanism of action of DNA pol ...

Dopamine under control: Precision regulation of inhibition shapes learning, memory and mental health

For decades, dopamine has been celebrated in neuroscience as the quintessential "reward molecule"—a chemical herald of ...

Eleven novel factors essential for mouse zygote development discovered

A research team led by Associate Professor Hirofumi Nishizono and graduate student Masaki Kato from the Research Support ...